Study Type definition

Study Type means the nature of the investigation or investigational use for which clinical trial information is being submitted, e.g., interventional, observational.
Sample 1Sample 2Sample 3
Study Type. Installation of a 25 Mar Shunt Capacitor Bank (TP-2008-05) Requestor: PNM Location: Yah-Ta- Hey Switching Station On July 3, 2008, PNM filed with the NMPRC a request under NMPRC Rule 440 to install a 25 Mvar shunt capacitor bank at the Yah-Ta-Hey 115kV switching station to address near-term transmission system voltage problems to comply with NERC, WECC and PNM Planning and Performance Criteria. This upgrade will add voltage support to PNM’s electric transmission system servicing western New Mexico and will maintain adequate and reliable service to existing loads located on that portion of the system. The target completion date for the line upgrade is 2010.
Sample 1Sample 2
Study Type. Red Mesa Switching Station (TP-2010-01) Requestor: PNM Location: Cibola County, NM On May 14, 2010, PNM filed with the NMPRC a request under NMPRC Rule 440 to complete certain transmission system enhancement/upgrades association with the interconnection of the NextEra Energy Resources LLC (“NextEra”) 102 MW wind generation facility (“Red Mesa Switching Station”). The Switching Station will be located approximately 7 miles west of PNM’s Xxxxxxx Tap on the 115 kV KM transmission line. The purpose of this project is to provide interconnection of a 102 MW wind generation facility to PNM’s 115 xX Xxxx Mesa-Ambrosia transmission line by NextEra by October 2010.
Sample 1Sample 2

Examples of Study Type in a sentence

  • Location Narrative; Roadway Alternatives, Traffic analysis, traffic and transportation technical report per ODOT and FHWA guidance; Bridge Alternative Study; Type, Size, and Location Report.

  • New information obtained about the Product during the performance of the Study The Sponsor agrees to provide the following equipment (hereinafter, the "Equipment") during the conduct of the Study: Type of Equipment: [•] Model: [•] Series: [•] Units to be provided to HUVH / VHIO: [•] Price: [•] (VAT included) Temporalidad: During the Study.

  • All traffic count data required for the purpose of this study will either be provided by the DEPARTMENT or will be obtained by the CONSULTANT under Study Type IV.

  • New information obtained about the Product during the performance of the Study The Sponsor agrees to provide the following equipment (hereinafter, the "Equipment") during the conduct of the Study: Type of Equipment: [•] Model: [•] Series: [•] Units to be provided to HUVH / VHIR: [•] Price: [•] (VAT included) Temporalidad: During the Study.

  • Title: A Multicenter Study for the Long-term Follow-up of HLH Patients who Received Treatment with NI-0501, an Anti- interferon Gamma Monoclonal Antibody Sponsor: Sobi AG, Switzerland Study Type: International, multicenter, long-term, follow-up study of haemophagocytic lymphohistiocytosis (HLH) patients who have received NI-0501 (INN assigned name: emapalumab) in the context of a previous NI-0501 clinical study in which no long-term follow-up is planned.

  • Data collection included the following variables: The Trial Title; Xxxxxxxxxxxxxx.xxx Identifier; First Received Date (the date on which summary clinical study protocol information was first submitted to the XxxxxxxxXxxxxx.xxx registry); Study Start Date; Study Completion Date; Sponsors; Collaborators; Study Type (Interventional); Condition; Intervention; Total Number of Patients; Mean Patients Age.

  • PhD Subject / Field of PhD Study: Type of Doctorate: (Individual doctorate, doctoral program xy or Cotutelle de thèse) Form and Language: Start Date: Envisaged Submission Date: Total number of credit points to be obtained, including requirements: ECTS Appendices: Individual Plan of Study, Overview of Supervisory Meetings Upon mutual consent, this Doctoral Agreement may be dissolved at any time up until the doctoral candidate’s formal application for his or her doctoral examination.


More Definitions of Study Type

Study Type. Rio Puerco Expansion (TP-2008-01) Requestor: PNM Location: Xxxxxxxx County On March 20, 2008, PNM filed with the NMPRC a request under NMPRC Rule 440 to development of a new 345 kV and 115 kV switching station by expanding PNM’s existing Rio Puerco series capacitor station. This project will also consist of the installation of a 345-115 kV bulk transformer, the construction of 13 miles of 115 kV line, and ground clearance improvements to the existing Veranda to Corrales Bluff 115 kV line to allow for a higher thermal ampacity rating. The purpose of this project is to improve system reliability and provide the needed additional transmission delivery source into the fast growing area of southwest Xxxxxxxx County (Northwest Albuquerque and the City of Rio Rancho area) by 2010 to comply with NERC, WECC and PNM Planning and Performance Criteria. The project in-service date is Fall 2010.
Sample 1
Study Type. Expansion/Upgrade of the Xxxxxxx 115 kV Station (TP-2008-07) Requestor: PNM Location: Xxxxxxx 115 kV Station On August 15, 2008, PNM filed with the NMPRC a request under NMPRC Rule 440 complete certain transmission system enhancements/upgrades in association with the interconnection of the High Lonesome Mesa, LLC (“HLM”) 100 MW nameplate capacity wind-powered electric generation facility (wind generator). The wind generator will be located approximately 13 miles south of the Tri-State Generation and Transmission Association, Inc. (“Tri-State”) Xxxxxxx 115 kV Switching Station (“Willard Station”), near Willard, New Mexico, and will interconnect to the PNM transmission system via Xxxxxxx Station. PNM will complete (or cause to be completed) the following transmission system enhancement/upgrades: • Expansion/upgrade of the Tri-State owned Willard Station, near Willard, New Mexico. • Upgrade of the PNM owned Xxxxxxx to Algodones (“AW”) 115 kV Line. • Rebuild of the PNM owned Xxxxxxx to Belen (“WL”) 115 kV Line. • Installation of a flow control device at the PNM owned Belen 115 kV Switching Station on the Tri-State owned Xxxxx-Xxxxxxx 115 kV Line. HLM has a firm point-to-point transmission service of 100 MW from the wind generator interconnection to the Four Corners 345 kV Switchyard. However, HLM will not be able to fully utilize the 100 MW of transmission service until the PNM transmission system improvements (i.e., the AW 115 kV Line upgrade, rebuild of the WL 115 kV Line, and installation of a flow control device at Belen 115 kV Switching Station on the Belen – Xxxxxxx 115 kV Line) are completed. Until that occurs, conditional firm transmission service will be provided, and the wind generator output will be controlled in response to system reliability directives (either electronic or verbal) issued by PNM. The HLM has been on-line since May 2009. Updates for the remaining transmission system improvements items are listed below: -Rebuild of the PNM owned Xxxxxxx to Xxxxx (“WL”) 115 kV Line by May 2010 - completed -Installation of a flow control device at the PNM owned Belen 115 kV Switching Station on the Tri-State owned Xxxxx-Xxxxxxx 115 kV Line by March 2011 - completed On August 11, 2008 an Large Generator Interconnection Agreement (pursuant to the PNM OATT) was executed between PNM and HLM. Status of PNM’s Transmission Studies 5/28/2010 Study Type: Xxxxxxx Substation (TP-2008-09) Requestor: PNM Location: Cibola County, NM On April 21, 2010, PNM filed wit...
Sample 1
Study Type. A Single Dose Pharmacokinetic Study of Recombinant Human Growth Factor (FGF-1) in Rats Study Director: Xx. Xxxxxx Xxxxxx Sponsor’s Study No: MPI Research Study No.: 0000-000 XXX Research Proposal No.: 04-082217 Study Schedule: Estimated Start Date: November 17, 2004 Estimated Date of Terminal Necropsy: To Be Determined Estimated Audited Draft Report Date: To Be Determined Study Price: $13,900 Original Payment Schedule: Animal Acquisition $8,300 30 Days After Initial Billing $4,200 At Mailing of Audited Draft Report $1,400 THE WORK DESCRIBED IN THIS PROTOCOL WILL BE DONE UNDER THE TERMS AND CONDITIONS OF THE MASTER AGREEMENT BETWEEN MPI RESEARCH AND (Enter Sponsor Here) DATED (Enter Date Here) AND THIS ADDENDUM NO. IS INCORPORATED INTO AND MADE A PART OF SAID MASTER AGREEMENT. MODIFICATIONS TO THE STUDY PRICE, MUTUALLY AGREED UPON IN WRITING BY THE PARTIES, THAT OCCUR DURING THE COURSE OF THE ABOVE DEFINED PAYMENT SCHEDULE WILL BE REFLECTED ON THE NEXT SCHEDULED INVOICE, UNLESS OTHERWISE NOTED. /s/ XXXX XXXXXX /s/ XXXXXXX XXXXXX On behalf of (Enter Sponsor Here) On behalf of MPI Research, Inc.
Sample 1

Related to Study Type

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • Phase 1 means the phase of the ATP comprised of: (1) improvements to the State Street Substation; (2) construction of the Proposed Line; (3) the rebuilding of NYSEG’s existing Lines 971 and 000 xxxxx xx Xxxxxxxx Xxxx xx the NYSEG ROW to allow for construction of the Proposed Line as intended; (4) improvements to the Elbridge Substation to accept the Proposed Line; and (5) National Grid’s conveyance to NYSEG of the NYSEG Acquired ROW and such other land interests as contemplated by the Purchase and Sale Agreement.

  • Tests after Completion means the tests (if any) which are specified in the Contract and which are carried out in accordance with the Specification after the Works or a Section (as the case may be) are taken over by the Procuring Entity.

  • Genetic testing means an analysis of genetic markers to exclude or identify a man as the father or a woman as the mother of a child. The term includes an analysis of one or a combination of the following:

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Timeline means the list of critical dates and actions included in the Introductory Materials.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase III means Phase I (or Phase I/II), Phase II (or Phase II/III) and Phase III clinical trials, respectively, in each case as prescribed by applicable FDA IND Regulations, or any corresponding foreign statutes, rules or regulations.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Clinical review criteria means the written screening procedures, decision abstracts, clinical protocols, and practice guidelines used by a health carrier to determine the necessity and appropriateness of health care services.

  • Acceptance Testing mean the tests, reviews and other activities that are performed by or on behalf of Agency to determine whether the Deliverables meet the Acceptance Criteria or otherwise satisfy the Agency, as determined by the Agency in its sole discretion.

  • Diagnosis of autism spectrum disorder means medically necessary assessments, evaluations, or tests

  • Phase 2 means the phase of the ATP comprised of: (1) improvements to the State Street Substation to receive Rebuilt Line 972; (2) the rebuilding of NYSEG’s existing Line 972 not performed in Phase 1; (3) construction of Relocated Line 15; (4) the construction of Bused Line 5; (5) improvements to the Elbridge Substation to receive Relocated Line 15; and (6) improvements to the Elbridge Substation to receive Bused Line 5.